Manulife (Manufacturers Life Insurance)’s MapLight Therapeutics MPLT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio MPLT Stock Details MPLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$252K	Buy	+7,040	New	+$202K	﹤0.01%	2465

Other funds holding MPLT

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Manulife (Manufacturers Life Insurance)'s MPLT Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) opened a new position in MapLight Therapeutics (MPLT) in Q2 2026: 7,040 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #2465 among its holdings.

100 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

Manulife (Manufacturers Life Insurance) held 7,040 shares of MapLight Therapeutics worth $252K as of Q2 2026.
MapLight Therapeutics was a new Manulife (Manufacturers Life Insurance) position in Q2 2026.
MapLight Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2465 holding.
100 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.